1
|
Leal C, Gualter Baptista M, Marques R, Pinto-de-Sousa J. Unveiling a Small Bowel Obstruction: A Case of a Neuroendocrine Ileal Tumor. Cureus 2024; 16:e66646. [PMID: 39258097 PMCID: PMC11386940 DOI: 10.7759/cureus.66646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/07/2024] [Indexed: 09/12/2024] Open
Abstract
Neuroendocrine tumors (NETs) are rare, slow-growing tumors originating from the diffuse neuroendocrine cell system, predominantly affecting the digestive tract. Small bowel neuroendocrine tumors (SBNETs) may present with nonspecific symptoms, such as abdominal pain, or with intermittent intestinal obstruction. This case outlines the diagnostic journey of a septuagenarian male with prolonged abdominal symptoms and weight loss. Despite extensive investigation, a definitive cause remained elusive. Recurrent partial intestinal obstruction led to surgical exploration and segmental resection. Pathology confirmed a NET. The case underscores the importance of considering intestinal neoplasia in older patients with recurrent partial small bowel obstruction.
Collapse
Affiliation(s)
- Clara Leal
- General Surgery, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Vila Real, PRT
- General Surgery, Clinical Academic Centre Trás-os-Montes e Alto Douro, Vila Real, PRT
| | - Maria Gualter Baptista
- General Surgery, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Vila Real, PRT
- General Surgery, Clinical Academic Centre Trás-os-Montes e Alto Douro, Vila Real, PRT
| | - Rita Marques
- General Surgery, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Vila Real, PRT
- General Surgery, Clinical Academic Centre Trás-os-Montes e Alto Douro, Vila Real, PRT
| | - João Pinto-de-Sousa
- General Surgery, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Vila Real, PRT
- General Surgery, Clinical Academic Centre Trás-os-Montes e Alto Douro, Vila Real, PRT
| |
Collapse
|
2
|
Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J, Liu X, Wang Y, Zhang S, Lu S, Lang J, Zhao Y. The roles of tissue resident macrophages in health and cancer. Exp Hematol Oncol 2024; 13:3. [PMID: 38229178 PMCID: PMC10790434 DOI: 10.1186/s40164-023-00469-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Accepted: 12/28/2023] [Indexed: 01/18/2024] Open
Abstract
As integral components of the immune microenvironment, tissue resident macrophages (TRMs) represent a self-renewing and long-lived cell population that plays crucial roles in maintaining homeostasis, promoting tissue remodeling after damage, defending against inflammation and even orchestrating cancer progression. However, the exact functions and roles of TRMs in cancer are not yet well understood. TRMs exhibit either pro-tumorigenic or anti-tumorigenic effects by engaging in phagocytosis and secreting diverse cytokines, chemokines, and growth factors to modulate the adaptive immune system. The life-span, turnover kinetics and monocyte replenishment of TRMs vary among different organs, adding to the complexity and controversial findings in TRMs studies. Considering the complexity of tissue associated macrophage origin, macrophages targeting strategy of each ontogeny should be carefully evaluated. Consequently, acquiring a comprehensive understanding of TRMs' origin, function, homeostasis, characteristics, and their roles in cancer for each specific organ holds significant research value. In this review, we aim to provide an outline of homeostasis and characteristics of resident macrophages in the lung, liver, brain, skin and intestinal, as well as their roles in modulating primary and metastatic cancer, which may inform and serve the future design of targeted therapies.
Collapse
Affiliation(s)
- Minmin Cao
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Zihao Wang
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - Wanying Lan
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
- Guixi Community Health Center of the Chengdu High-Tech Zone, Chengdu, China
| | - Binghua Xiang
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - Wenjun Liao
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
| | - Jie Zhou
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
| | - Xiaomeng Liu
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
| | - Yiling Wang
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
| | - Shichuan Zhang
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
| | - Shun Lu
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
| | - Jinyi Lang
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
| | - Yue Zhao
- Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
| |
Collapse
|
3
|
Sedhai S, Mohammed F, Sahtiya S, Sanaullah S, Pritwani P, Saleem F, Abere A, Ghaffari MAZ. Pancreatic Neuroendocrine Tumor (PNET) Presenting as a Pseudocyst: A Case Report. Cureus 2022; 14:e29617. [DOI: 10.7759/cureus.29617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/26/2022] [Indexed: 11/05/2022] Open
|
4
|
Costa RDD, Kemp R, Santos JSD, Costa DAPD, Ardengh JC, Ribas-Filho JM, Ribas CAPM. THE ROLE OF CONVENTIONAL ECHOENDOSCOPY (EUS) IN THERAPEUTIC DECISIONS IN PATIENTS WITH NEUROENDOCRINE GASTROINTESTINAL TUMORS. ACTA ACUST UNITED AC 2020; 33:e1512. [PMID: 32844878 PMCID: PMC7448866 DOI: 10.1590/0102-672020190001e1512] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2020] [Accepted: 04/23/2020] [Indexed: 12/14/2022]
Abstract
Background:
Gastrointestinal neuroendocrine tumors are rare, usually presented as
subepithelial or polypoid tumors. Accurate diagnosis and indication of the
type of resection are still challenging.
Aim:
To determine the effectiveness of echoendoscopy in determining the depth of
the lesions (T) identified by endoscopy in order to evaluate surgical and/or
endoscopic indication, and to evaluate the results of endoscopic removal in
the medium term.
Methods:
Twenty-seven patients were included, all of whom underwent echoendoscopy for
TN tumor staging and the evaluation of possible endoscopic resection. The
parameters were: lesion size, origin layer, depth of involvement and
identified perilesional adenopathies. The inclusion criteria for endoscopic
resection were: 1) high surgical risk; 2) those with NET <2 cm; 3)
absence of impairment of the muscle itself; and 4) absence of perilesional
adenopathies in echoendoscopy and in others without distant metastases.
Exclusion criteria were TNE> 2 cm; those with infiltration of the muscle
itself; with perilesional adenopathies and distant metastases. The
techniques used were: resection with polypectomy loop; mucosectomy with
saline injection; and mucosectomy after ligation with an elastic band. The
anatomopathological study of the specimens included evaluation of the
margins and immunohistochemistry (chromogranin, synaptophysin and Ki 67) to
characterize the tumor. Follow-up was done at 1, 6 and 12 months.
Results:
Resections with polypectomy loop were performed in 15 patients; mucosectomy
in five; mucosectomy and ligation with elastic band in three and the
remaining four were referred for surgery. The anatomopathological specimens
and immunohistochemical analyzes showed positive chromogranin and
synaptophysin, while Ki 67 was less than 5% among all cases. The medium-term
follow-up revealed three recurrences. The average size of tumors in the
stomach was 7.6 mm and in the duodenum 7.2 mm. Well-demarcated, hypoechoic,
homogeneous lesions occurred in 75%; mucous layer in 80%; and the deep and
submucosal mucosa in 70%.
Conclusions:
Echoendoscopy proved to be a good method for the study of subepithelial
lesions, being able to identify the layer affected by the neoplasm, degree
of invasion, echogenicity, heterogeneity, size of the lesion and
perilesional lymph node involvement and better indicate the treatment
option.
Collapse
Affiliation(s)
- Rodrigo Dias da Costa
- Medical Research Institute, University Evangelical Hospital of Curitiba, Evangelical Faculty of Paraná, Curitiba, PR, Brazil
| | - Rafael Kemp
- Hospital das Clínicas, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | - José Sebastião Dos Santos
- Hospital das Clínicas, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | | | - José Celso Ardengh
- Medical Research Institute, University Evangelical Hospital of Curitiba, Evangelical Faculty of Paraná, Curitiba, PR, Brazil
| | - Jurandir Marcondes Ribas-Filho
- Medical Research Institute, University Evangelical Hospital of Curitiba, Evangelical Faculty of Paraná, Curitiba, PR, Brazil
| | | |
Collapse
|